Journey Medical Corp
10-K
March 26, 2026
Key Highlights
- FDA approval of Emrosi in April 2024 offers a potential blockbuster growth catal...
- Revenue grew 8.3% year-over-year to $128.5 million.
- Strategic international licensing deals, such as the Cutia Therapeutics agreemen...
Read Analysis
🤖 AI Generated